OpenLegislation

Annex

United Kingdom

Original text. Later amendments are not shown.

The following entry shall be added at the end of the table in Annex I to Directive 91/414/EEC.

Further details on identity and specification of active substance are provided in the review report.’

‘NoCommon name, identification numbersIUPAC namePurityf1 Entry into forceExpiration of inclusionSpecific provisions
143

Fenamiphos

CAS No 22224-92-6

CIPAC No 692

(RS)-ethyl 4-methylthio-m-tolyl isopropyl-phosphoramidate≥ 940 g/kg1 August 200731 July 2017

PART A

Only uses as nematicide applied by drip irrigation in greenhouses with permanent structure may be authorised.

PART B

For the implementation of the uniform principles of Annex VI, the conclusions of the review report on fenamiphos, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 14 July 2006 shall be taken into account.

In this overall assessment:

  • Member States must pay particular attention to the protection of aquatic organisms, soil non-target organisms and groundwater in vulnerable situations.

Conditions of authorisation should include risk mitigation measures and monitoring programmes should be initiated to verify potential groundwater contamination in vulnerable zones, where appropriate.

144

Ethephon

CAS No 16672-87-0

CIPAC No 373

2-chloroethyl-phosphonic acid

≥ 910 g/kg (technical material — TC)

The manufacturing impurities MEPHA (Mono 2-chloroethyl ester, 2-chloroethyl phosphonic acid) and 1,2-Dichloroethane are of toxicological concern and must not exceed respectively 20 g/kg and 0,5 g/kg in the technical material.

1 August 200731 July 2017

PART A

Only uses as plant growth regulator may be authorised.

PART B

For the implementation of the uniform principles of Annex VI, the conclusions of the review report on ethephon, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 14 July 2006 shall be taken into account.

Annotations

Footnotes

f1

Further details on identity and specification of active substance are provided in the review report.’